Detailed answers about CEREBROVASCULAR SOLUTIONS LONDON LIMITED, including incorporation, status, business activity, and accounts information.
When was CEREBROVASCULAR SOLUTIONS LONDON LIMITED founded?
CEREBROVASCULAR SOLUTIONS LONDON LIMITED was officially incorporated on 19 February 2026 and is registered under company number 17042607. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is CEREBROVASCULAR SOLUTIONS LONDON LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of CEREBROVASCULAR SOLUTIONS LONDON LIMITED?
CEREBROVASCULAR SOLUTIONS LONDON LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does CEREBROVASCULAR SOLUTIONS LONDON LIMITED do?
CEREBROVASCULAR SOLUTIONS LONDON LIMITED operates in the following sector: 86220 - Specialists medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is CEREBROVASCULAR SOLUTIONS LONDON LIMITED's registered address?
The registered office address of CEREBROVASCULAR SOLUTIONS LONDON LIMITED is 56 CHORLEY NEW ROAD, BOLTON, LANCASHIRE, UNITED KINGDOM, BL1 4AP. This is the official address filed with Companies House for legal and statutory correspondence.
Is CEREBROVASCULAR SOLUTIONS LONDON LIMITED financially stable?
Financial accounts for CEREBROVASCULAR SOLUTIONS LONDON LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.